Equity Profile

SNN

Smith & Nephew plc

Health CareHealth Care Equipment$12.6B

Feb20Thu

Pre-Earnings Brief

UpcomingQ4-2019Pre-Market9:00 AM EST

Company Snapshot

Smith & Nephew plc (SNN) is a global medical technology company that specializes in advanced wound management, orthopedic reconstruction, and sports medicine. Operating in the health care sector, the company plays a crucial role in providing innovative solutions that improve patient outcomes and enhance the quality of life.

Key Metrics to Watch

Revenue Growth

Revenue growth is essential to gauge the company's ability to expand its market presence and meet demand in the health care equipment sector.

N/A

Earnings Per Share (EPS)

EPS is a critical measure of profitability and can influence investor sentiment and stock price.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q4-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported earnings that met expectations, with a modest increase in stock price following the announcement. The company continued to focus on innovation and expanding its product lines.

Management Promises & Guidance

Commitment to enhancing product offerings in advanced wound management.
Focus on increasing operational efficiency.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Overall expectations for Smith & Nephew's upcoming earnings report are mixed, with investors looking for signs of growth amid competitive pressures. Analysts are particularly focused on revenue growth and profitability metrics.

Bull Case

The optimistic view hinges on strong revenue growth driven by new product launches and increased market share, which could lead to a positive stock reaction.

Bear Case

Conversely, if the company reports disappointing earnings or fails to show significant growth, it could lead to a decline in stock price, reflecting investor concerns about market competition.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for the upcoming quarter?

Revenue growth is a key indicator of the company's health and ability to compete in the market, making it a focal point for investors.

How is Smith & Nephew addressing competition in the health care equipment sector?

Understanding the company's strategy to manage competition will provide insights into its long-term sustainability and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the impact of new product launches on revenue growth this quarter, as Smith & Nephew has been investing heavily in innovation.

Supporting Evidence

Recent trends in advanced wound management indicate a growing market that Smith & Nephew is well-positioned to capitalize on.

The company's focus on operational efficiency may lead to better-than-expected margins, countering concerns about competition.

Key Risk

If new product sales exceed expectations, it could significantly shift investor sentiment and challenge current consensus views.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized as it reflects the company's ability to navigate a competitive landscape and deliver growth.

Bull Confirmed If

A revenue growth rate of over 10% would confirm the bull case and indicate strong demand for Smith & Nephew's products.

Bear Confirmed If

A revenue decline or stagnation could confirm the bear case, raising concerns about the company's market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of 5%, indicating that investors expect some volatility around the earnings report.

Options are pricing ±5.0% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

25.2%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could react positively, potentially moving up by around 2.38% on the first day.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see limited movement as investors reassess future growth.

Miss

A miss on earnings could lead to a decline, with historical patterns indicating an average drop of about 1.11% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on revenue growth from new product lines.
2Updates on market share changes in key segments.
3Management's strategy for addressing competitive pressures.
4Any commentary on operational efficiency improvements.
5Insights into expansion plans in emerging markets.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Feb17

SCIReported

Service Corporation International

RecapView

Feb17

FLSReported

Company Snapshot

Key Metrics to Watch

Revenue Growth

Revenue growth is essential to gauge the company's ability to expand its market presence and meet demand in the health care equipment sector.

N/A

Earnings Per Share (EPS)

EPS is a critical measure of profitability and can influence investor sentiment and stock price.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q4-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

Management Promises & Guidance

Commitment to enhancing product offerings in advanced wound management.
Focus on increasing operational efficiency.
Plans to expand into emerging markets.

Expectations

Wall Street Expectations

Bull Case

The optimistic view hinges on strong revenue growth driven by new product launches and increased market share, which could lead to a positive stock reaction.

Bear Case

Conversely, if the company reports disappointing earnings or fails to show significant growth, it could lead to a decline in stock price, reflecting investor concerns about market competition.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for the upcoming quarter?

Revenue growth is a key indicator of the company's health and ability to compete in the market, making it a focal point for investors.

How is Smith & Nephew addressing competition in the health care equipment sector?

Understanding the company's strategy to manage competition will provide insights into its long-term sustainability and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the impact of new product launches on revenue growth this quarter, as Smith & Nephew has been investing heavily in innovation.

Supporting Evidence

Recent trends in advanced wound management indicate a growing market that Smith & Nephew is well-positioned to capitalize on.

The company's focus on operational efficiency may lead to better-than-expected margins, countering concerns about competition.

Key Risk

If new product sales exceed expectations, it could significantly shift investor sentiment and challenge current consensus views.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely scrutinized as it reflects the company's ability to navigate a competitive landscape and deliver growth.

Bull Confirmed If

A revenue growth rate of over 10% would confirm the bull case and indicate strong demand for Smith & Nephew's products.

Bear Confirmed If

A revenue decline or stagnation could confirm the bear case, raising concerns about the company's market competitiveness.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of 5%, indicating that investors expect some volatility around the earnings report.

Options are pricing ±5.0% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

25.2%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could react positively, potentially moving up by around 2.38% on the first day.

In-Line / Cautious

If results are in line with expectations but management provides cautious commentary, the stock may see limited movement as investors reassess future growth.

Miss

A miss on earnings could lead to a decline, with historical patterns indicating an average drop of about 1.11% following such outcomes.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on revenue growth from new product lines.
2Updates on market share changes in key segments.
3Management's strategy for addressing competitive pressures.
4Any commentary on operational efficiency improvements.
5Insights into expansion plans in emerging markets.